ES2106936T5 - Derivados de carbazolona y procedimientos para su preparacion. - Google Patents

Derivados de carbazolona y procedimientos para su preparacion.

Info

Publication number
ES2106936T5
ES2106936T5 ES93116542T ES93116542T ES2106936T5 ES 2106936 T5 ES2106936 T5 ES 2106936T5 ES 93116542 T ES93116542 T ES 93116542T ES 93116542 T ES93116542 T ES 93116542T ES 2106936 T5 ES2106936 T5 ES 2106936T5
Authority
ES
Spain
Prior art keywords
formula
group
methyl
carbazolona
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93116542T
Other languages
English (en)
Other versions
ES2106936T3 (es
Inventor
Peter Dr Bod
Kalman Dr Harsanyi
Ferenc Dr Trischler
Eva Fekecs
Attila Csehi
Bela Dr Hegedus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26318102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2106936(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from HU9203223A external-priority patent/HU212785B/hu
Priority claimed from HU9203222A external-priority patent/HU212934B/hu
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of ES2106936T3 publication Critical patent/ES2106936T3/es
Application granted granted Critical
Publication of ES2106936T5 publication Critical patent/ES2106936T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

LA INVENCION SE REFIERE A DERIVADOS DE CARBAZOLONA DE LA FORMULA (I) EN LA QUE A REPRESENTA UN GRUPO DE FORMULA (V) EN LA QUE R REPRESENTA UN GRUPO HIDROXILO O 2-METIL-1H-IMIDAZOL-1-ILO; B REPRESENTA UN GRUPO DE FORMULA (VI) EN LA QUE R1 REPRESENTA HIDROGENO O UN GRUPO METILO O ETILO; O A Y B JUNTOS FORMAN UN GRUPO DE FORMULA (VII), EN LA QUE R2 REPRESENTA UN GRUPO METILO O ETILO; O A Y B JUNTOS FORMAN UN GRUPO DE FORMULA (VIII). LOS COMPUESTOS MENCIONADOS SON QUIMICAMENTE UTILES COMO INTERMEDIOS EN LA SINTESIS DE ONDASENTRON DE FORMULA (II) 9-METIL-3-[(2-METIL-1H-IMIDAZOL-1IL)METIL]-1,2,3,9-TETRAHIDRO-4H-CARBAZOL-4-ONA. LA INVENCION SE REFIERE ADEMAS A UN NUEVO PROCESO PARA LA PREPARACION DE COMPUESTOS DE LA FORMULA (I), EN LA QUE A Y B SON IGUALES QUE EN LA FORMULA (I).
ES93116542T 1992-10-14 1993-10-13 Derivados de carbazolona y procedimientos para su preparacion. Expired - Lifetime ES2106936T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9203223A HU212785B (en) 1992-10-14 1992-10-14 Process for producing of a carbazolone derivative
HU9203222A HU212934B (en) 1992-10-14 1992-10-14 Process for producing novel alkoxalylated carbazolone derivatives

Publications (2)

Publication Number Publication Date
ES2106936T3 ES2106936T3 (es) 1997-11-16
ES2106936T5 true ES2106936T5 (es) 2001-12-16

Family

ID=26318102

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93116542T Expired - Lifetime ES2106936T5 (es) 1992-10-14 1993-10-13 Derivados de carbazolona y procedimientos para su preparacion.

Country Status (20)

Country Link
US (2) US5416221A (es)
EP (1) EP0595111B2 (es)
JP (1) JP3378315B2 (es)
KR (1) KR100289912B1 (es)
CN (2) CN1052979C (es)
AT (1) ATE157973T1 (es)
CA (1) CA2106642C (es)
CZ (1) CZ284223B6 (es)
DE (1) DE69313771T3 (es)
DK (1) DK0595111T4 (es)
EE (1) EE03071B1 (es)
ES (1) ES2106936T5 (es)
GR (1) GR3025599T3 (es)
HR (1) HRP931292B1 (es)
PL (2) PL174526B1 (es)
RO (1) RO115799B1 (es)
RU (1) RU2119914C1 (es)
SI (1) SI9300537B (es)
SK (1) SK281243B6 (es)
UA (2) UA26893C2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226135B1 (en) * 2000-03-28 2008-05-28 Richter Gedeon Nyrt Intermediate of ondansetron and process for its production
KR100368895B1 (ko) * 2000-03-30 2003-01-24 하나제약 주식회사 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온의 제조방법
CN1498216A (zh) * 2000-10-30 2004-05-19 ������ҩ��ҵ���޹�˾ 新的奥丹西隆盐酸盐晶体和溶剂化物及其制备方法
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
ES2288606T3 (es) * 2002-04-29 2008-01-16 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Procedimiento para preparar 1,2,3,9-tetrahidro-9-metil-3-((2-metil-1h-imidazol-1-il)metil)-4h-carbazol-4-ona.
JP2005529908A (ja) * 2002-04-30 2005-10-06 テバ ジョジセルジャール レースベニュタールシャシャーグ オンダンセトロンの新規結晶形、その製法、当該新規形を含有する医薬組成物、及び当該組成物を用いる吐気の治療方法
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
JP2008505965A (ja) * 2004-07-12 2008-02-28 カディラ ヘルスケア リミティド カンナビノイド受容体修飾因子としての三環式ピラゾール誘導体
US7696356B2 (en) * 2004-08-17 2010-04-13 Taro Pharmaceutical Industries Limited Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
US7547791B2 (en) * 2004-10-26 2009-06-16 Ipca Laboratories Ltd. One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O
CN115677561B (zh) * 2022-11-01 2024-04-05 常州兰陵制药有限公司 一种1,2,3,4-四氢-9-甲基-4h-咔唑酮及其合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579534A (en) * 1969-05-09 1971-05-18 American Cyanamid Co Tetrahydrocarbazolecarboxylates
CN1011237B (zh) * 1984-01-25 1991-01-16 格拉克索公司 1，2，3，9-四氢-3-[(2-甲基-1h-咪唑-1-基)甲基]-4h-咔唑-4-酮类和其盐以及溶剂化物的制备
LU88268I2 (es) * 1984-01-25 1994-02-03
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
GB8628473D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Chemical compounds
EP0317088A1 (en) * 1987-10-22 1989-05-24 Glaxo Group Limited Ketone derivatives

Also Published As

Publication number Publication date
PL174173B1 (pl) 1998-06-30
DE69313771T2 (de) 1998-02-12
SI9300537A (en) 1994-06-30
DK0595111T4 (da) 2001-10-22
SK111093A3 (en) 1994-11-09
US5416221A (en) 1995-05-16
ES2106936T3 (es) 1997-11-16
CN1052979C (zh) 2000-05-31
DE69313771T3 (de) 2002-04-18
EE03071B1 (et) 1998-02-16
HRP931292A2 (en) 1994-12-31
JP3378315B2 (ja) 2003-02-17
US5478949A (en) 1995-12-26
GR3025599T3 (en) 1998-03-31
CN1089941A (zh) 1994-07-27
UA26893C2 (uk) 1999-12-29
CN1235967A (zh) 1999-11-24
RO115799B1 (ro) 2000-06-30
SK281243B6 (sk) 2001-01-18
RU2119914C1 (ru) 1998-10-10
EP0595111B1 (en) 1997-09-10
DK0595111T3 (da) 1998-04-14
SI9300537B (sl) 2003-02-28
HRP931292B1 (en) 1999-08-31
ATE157973T1 (de) 1997-09-15
PL174526B1 (pl) 1998-08-31
EP0595111A1 (en) 1994-05-04
PL300685A1 (en) 1994-04-18
DE69313771D1 (de) 1997-10-16
EP0595111B2 (en) 2001-08-16
UA27022C2 (uk) 2000-02-28
CN1083430C (zh) 2002-04-24
JPH06293734A (ja) 1994-10-21
KR100289912B1 (ko) 2001-09-17
CA2106642A1 (en) 1994-04-15
CZ284223B6 (cs) 1998-09-16
KR940009152A (ko) 1994-05-20
CZ215693A3 (en) 1994-05-18
CA2106642C (en) 2005-08-16

Similar Documents

Publication Publication Date Title
FI842419A (fi) 2-pyrimidinyl-1-piperazin-derivat, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
YU48390B (sh) Novi derivati 2-anilinopirimidina, postupak za njihovo dobijanje i sredstva za uništavanje štetočina, koja sadrže ove derivate
ES2134755T3 (es) Derivados de quinolina como antagonistas de leucotrieno d4, composiciones que contienen los mismos y procedimientos para su preparacion.
ES2106936T5 (es) Derivados de carbazolona y procedimientos para su preparacion.
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
ES2039242T3 (es) Un procedimiento para la preparacion de nuevos derivados de piperidina.
AR035153A1 (es) Derivados de carboxamidas y cetonas de dihidrobenzodioxina
DE69133295D1 (de) 3,9-diazabicyclo-[3.3.1]-nonanylderivate, verfahren und intermediate für ihre darstellung und sie enthaltende pharmazeutische zusammensetzungen
FI803264L (fi) 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
ES2115650T3 (es) Derivados de tiazolidina que contienen un grupo quinona, su preparacion y utilizacion en terapeutica.
FI875596A0 (fi) Foerfarande foer framstaellning av tienyletylaminer och aeven ditienyletylaminer.
AR008168A1 (es) Compuestos etilamino arilamida aril substituidos de pirrolidinilo y pirrolinilo, composicion farmaceutica que lo contiene, compuesto util para susintesis, procedimiento para su preparacion
FI822099A0 (fi) Maettade aminocyklitderivat, deras framstaellning och dessa innehaollande laekemedel
ES2114115T3 (es) Procedimiento y nuevos productos intermedios para la obtencion de triazolinonas.
ES2159921T3 (es) Imidazolinas sustituidas por un nucleo heterociclico, como 2-alfa-antagonistas.
ES2141445T3 (es) Derivados triciclicos, su preparacion y su aplicacion a la preparacion de la colchicina y la tiocolchicina opticamente activos o racemicos y analogos o derivados o productos intermedios.
IE790771L (en) 1,2-disubstituted pyrrolidine and piperidine compounds.
ES2120483T3 (es) Alcoholes benzilo y benzhidrilo.
ES2108691T3 (es) Compuestos y composiciones absorbentes de uv.
ATE23147T1 (de) Ungesaettigte verbindungen, ihre herstellung und anwendung.
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
ES2038612T3 (es) Compuestos de hidroquinolina, composiciones que los contienen y procedimientos para prepararlas.
ES2053544T3 (es) Un procedimiento para la preparacion de nuevos derivados de indol tetraciclicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 595111

Country of ref document: ES